Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

European Union support for the Lebanese Healthcare System reaches €173 million

18 December 2018 - The European Union has renewed its commitment to strengthen the Lebanese health care system and secure access to chronic medications, vaccines and essential medical commodities to the most vulnerable population in Lebanon. Through an additional contribution of 19 million Euro from the EU Regional Trust Fund in response to the Syrian crisis, UNICEF and WHO will be able to support to people in need living in Lebanon by ensuring provision of primary healthcare services and strengthening the health system.
 
The additional funding was announced today during a joint press conference headed by the Minister of Public Health, Ghassan Hasbani, EU Ambassador Christina Lassen, WHO representative Dr. Imane Shankiti, and UNICEF Representative, Tanya Chapuisat. The donation is part of a package of support of 173 million Euro which the European Union has invested in the health sector to strengthen the system and to help meet the basic health needs of both Lebanese citizens and Syrian refugees in a time of great pressure on service delivery and health infrastructure.
 
“We thank the commitment of the European Union and the support of the World Health Organization and UNICEF in strengthening the healthcare system to meet the needs of both Lebanese and Syrian refugees,” said Minister Hasbany.
 
EU Ambassador Lassen highlighted that "the projects we are launching today are part of a 173 million Euro health package that includes primary and secondary healthcare and aims at achieving quality, affordable and accessible health services for everyone in need in Lebanon".
 
“The generous support of the EU to the health system has sealed a long-standing partnership between the MOPH, WHO and UNICEF, and ensured that health services were of good quality, and that outbreaks and health risks are identified and acted upon early enough” said Imane Shankiti, WHO representative. “Reinforcing the health system capacity, along with filling critical health services with EU support ensured that no patient in need for health care was left behind”.
 
“The strong partnership we have with the EU, the ministry of Public Health and WHO has ensured that every child in Lebanon has access to quality vaccines to remain safe from outbreaks of preventable diseases,” said Tanya Chapuisat, UNICEF Representative to Lebanon. “Through EU funding we are able to save lives and strengthen systems to shape a better future for children”.
 
 
    3
    ...
ATC Name B/G Ingredients Dosage Form Price
R01BA53 AURIMEL B Phenylephrine HCl - 5mg/5ml, Sodium citrate - 325mg/5ml, Carbinoxamine maleate - 2mg/5ml, Dextromethorphan HBr - 5mg/5ml Syrup 319,963 L.L
R06AX27 AERIUS B Desloratadine - 5mg 5mg Tablet, film coated 430,030 L.L
R06AX27 AERIUS B Desloratadine - 5mg 5mg Tablet, film coated 430,030 L.L
J07BX05 ABRYSVO B RSV subgroup A stabilized perfusion F antigen 60mcg - 60mcg, RSV subgroup B stabilized perfusion F antigen 60mcg - 60mcg, Glycoprotein F stabilized in the perfusion conformation - Injectable powder + solvent 22,650,721 L.L
L04AA13 ARAVA B Leflunomide - 10mg 10mg Tablet, film coated 2,230,779 L.L
N02BA01 ASPIRINE B Acetylsalicylic acid - 300mg 0.3g Tablet 80,631 L.L
L04AA13 ARAVA B Leflunomide - 20mg 20mg Tablet, film coated 3,346,168 L.L
N02BA51 ASPIRINE C EFFERVESCENT B Acetylsalicylic acid - 400mg, Vitamin C - 240mg Tablet, effervescent 162,605 L.L
J01MA14 AVALOX B Moxifloxacin (HCl) - 400mg 400mg Tablet, film coated 1,087,169 L.L
R06AX27 AERIUS B Desloratadine - 0.5mg/ml 0.5mg/ml Solution 403,153 L.L
J01MA14 AVALOX B Moxifloxacin (HCl) - 400mg 400mg Tablet, film coated 1,521,230 L.L
M01AE51 ADVIL COLD & SINUS B Ibuprofen - 200mg, Pseudoephedrine HCl - 30mg Caplet, coated 288,926 L.L
J01MA14 AVALOX B Moxifloxacin (HCl) - 400mg/250ml 400mg/250ml Injectable solution 9,052,935 L.L
L04AA31 AUBAGIO B Teriflunomide - 14mg 14mg Tablet, film coated 38,773,533 L.L
L04AA31 AUBAGIO B Teriflunomide - 14mg 14mg Tablet, film coated 38,773,533 L.L
G04CB02 AVODART B Dutasteride - 0.5mg 0.5mg Capsule 2,660,787 L.L
L04AD02 ADVAGRAF B Tacrolimus monohydrate - 1mg 1mg Capsule, prolonged release L.L
M01AH05 ARCOXIA B Etoricoxib - 60mg 60mg Tablet, film coated 1,685,178 L.L
L04AD02 ADVAGRAF B Tacrolimus monohydrate - 3mg 3mg Capsule, prolonged release L.L
C10BA05 ATOZET B Atorvastatin - 10mg, Ezetimibe - 10mg Tablet, film coated 1,624,706 L.L
C10BA05 ATOZET B Atorvastatin - 10mg, Ezetimibe - 10mg Tablet, film coated 1,624,706 L.L
R03AL01 ATROVENT COMP. HFA B Fenoterol Hydrobromide - 20mcg/actuation, Ipratropium bromide - 50mcg/actuation Inhalation aerosol metered dose 544,256 L.L
L01BA04 ALIMTA B Pemetrexed (disodium) - 500mg 500mg Injectable concentrated powder for solution 78,813,513 L.L
M01AH05 ARCOXIA B Etoricoxib - 90mg 90mg Tablet, film coated 2,119,240 L.L
C10BA05 ATOZET B Atorvastatin - 20mg, Ezetimibe - 10mg Tablet, film coated 2,046,672 L.L
C10BA05 ATOZET B Atorvastatin - 20mg, Ezetimibe - 10mg Tablet, film coated 2,046,672 L.L
R03AL03 ANORO ELLIPTA B Vilanterol - 25mcg, Umeclidinium bromide - 62.5mcg Inhalation powder 5,367,774 L.L
C10BA05 ATOZET B Atorvastatin - 40mg, Ezetimibe - 10mg Tablet, film coated 2,046,672 L.L
C10BA05 ATOZET B Atorvastatin - 40mg, Ezetimibe - 10mg Tablet, film coated 2,046,672 L.L
L01BA04 ALIMTA B Pemetrexed (disodium) - 100mg 100mg Injectable concentrated powder for solution 16,854,009 L.L
    3
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2025